[A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
D001572:Benzofurans / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D001572:Benzofurans; D014528:Uricosuric Agents; D014665:Vasodilator Agents; D014527:Uric Acid; D014969:Xanthine Oxidase
Un nuovo ipouricemizzante: il benziodarone. Sua applicazione nella terapia della ritenzione uratica in corso di insufficienza renale cronica.